MBX Biosciences (MBX) EPS (Weighted Average and Diluted) (2023 - 2026)
MBX Biosciences' (MBX) quarterly EPS (Weighted Average and Diluted) came in at -$0.5 in Q1 2026, up 29.58% year-on-year from -$0.39 in Q1 2025, and down 11.11% quarter-over-quarter from -$0.45 in Q4 2025.
MBX Biosciences (MBX) EPS (Weighted Average and Diluted) (2023 - 2026) Analysis & Trends
MBX Biosciences has disclosed EPS (Weighted Average and Diluted) across 4 years of filings, most recently posting -$0.5 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.5, up 29.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.16 (up 66.82% YoY), and the FY2025 annual result was -$2.38, up 59.11% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.5 for Q1 2026 at MBX Biosciences, down from -$0.45 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $9.6 in Q4 2024 to a low of -$12.62 in Q2 2024.
- The 4-year median for EPS (Weighted Average and Diluted) is -$0.71 (2025), against an average of -$3.27.
- Across the five-year window, EPS (Weighted Average and Diluted) surged 225.0% in 2024 and sank 104.69% in 2025, its largest moves.
- MBX Biosciences' EPS (Weighted Average and Diluted) stood at -$7.68 in 2023, then soared by 225.0% to $9.6 in 2024, then tumbled by 104.69% to -$0.45 in 2025, then slipped by 11.11% to -$0.5 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.5 (Q1 2026), -$0.45 (Q4 2025), and -$0.63 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | MBX Biosciences | 1.44 Bn | 1.44 Bn | - | -0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.50 |
| Dec 31, 2025 | -0.45 |
| Sep 30, 2025 | -0.63 |
| Jun 30, 2025 | -0.58 |
| Mar 31, 2025 | -0.71 |
| Dec 31, 2024 | 9.60 |
| Sep 30, 2024 | -2.78 |
| Jun 30, 2024 | -12.62 |
| Mar 31, 2024 | -10.26 |
| Dec 31, 2023 | -7.68 |
| Sep 30, 2023 | -9.40 |